BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31539115)

  • 1. CircRNA UBAP2 promotes the progression of ovarian cancer by sponging microRNA-144.
    Sheng M; Wei N; Yang HY; Yan M; Zhao QX; Jing LJ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7283-7294. PubMed ID: 31539115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
    Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
    Sun D; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/HMGA2 axis.
    Ma W; Xue N; Zhang J; Wang D; Yao X; Lin L; Xu Q
    Int J Oncol; 2021 Mar; 58(3):298-311. PubMed ID: 33650644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.
    Zhao Y; Hu Y; Shen Q; Chen Q; Zhu XJ; Jiang SS; Zhang Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5281-5291. PubMed ID: 32495861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway.
    Dong L; Qu F
    J Mol Histol; 2020 Aug; 51(4):329-340. PubMed ID: 32472335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA-100219 promotes breast cancer progression by binding to microRNA-485-3p.
    Yao Y; Fang ZZXHSLCNH
    J BUON; 2019; 24(2):501-508. PubMed ID: 31127997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.
    Liu T; Yuan L; Zou X
    J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer.
    Zhang L; Wang YH; Wang L
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6062-6069. PubMed ID: 31364107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
    Yao N; Yu L; Zhu B; Gan HY; Guo BQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
    Zhao YL; Huang YM
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNA UBAP2 facilitates the progression of colorectal cancer by regulating miR-199a/VEGFA pathway.
    Dai J; Zhuang Y; Tang M; Qian Q; Chen JP
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7963-7971. PubMed ID: 32767322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p.
    Zhu L; Liu Y; Yang Y; Mao XM; Yin ZD
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2817-2826. PubMed ID: 31002133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression.
    Yu MC; Ding GY; Ma P; Chen YD; Zhu XD; Cai JB; Shen YH; Zhou J; Fan J; Sun HC; Kuang M; Huang C
    Carcinogenesis; 2021 Oct; 42(10):1293-1303. PubMed ID: 34314478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC01308 accelerates the malignant progression of ovarian cancer by binding to miRNA-506.
    Zhang YY; Li P; Zhu MZ; Guo Y; Yang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3253-3260. PubMed ID: 31081077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of circular RNA UBAP2 inhibits the malignant behaviours of esophageal squamous cell carcinoma by microRNA-422a/Rab10 axis.
    Wu Y; Zhi L; Zhao Y; Yang L; Cai F
    Clin Exp Pharmacol Physiol; 2020 Jul; 47(7):1283-1290. PubMed ID: 32012318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
    Yu XY; Tian JR; Yang D; Tan HR
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.
    Jiang JH; Lv QY; Yi YX; Liao J; Wang XW; Zhang W
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6260-6267. PubMed ID: 30338796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.